The eTRANSAFE consortium met in Brussels at the end of the first year of the project to share experiences and discuss about first achievements. The meeting took place right after EuroTox 2018 conference, which several consortium members attended and where networking opportunities arose.
The 4th Consortium Meeting of the project was structured around workshops, also including a session to allow work packages updates. Discussions around specific topics ensured a deep involvement of all project participants. Carlos Díaz, SYNAPSE CEO, co-chaired a `Clinical Data´ session together with Johan van der Lei from Erasmus Medical Center. The aim of this workshop was to discuss data availability and to explore the options to embed different sources to support the translation from preclinical to clinical and vice versa.
A special workshop titled `Translational prediction – from vision to visualisation & User stories´ was organised, aiming at defining initial workflows to guide the development process. To this end, EFPIA use cases where shared. Those use cases presented potential challenges that eTRANSAFE translational analysis approaches would aim at addressing during the project life.
The eTRANSAFE project was launched on September 1st, 2017 and has been sponsored by the European Union’s Horizon 2020 research and innovation programme and the European pharmaceutical industry (via EFPIA) under the auspices of the Innovative Medicines Initiative 2 Joint Undertaking.
For more information contact firstname.lastname@example.org or check out http://etransafe.eu/.